Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Pyrimethamine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. This product is the only ABrated generic version Daraprim® (pyrimethamine) Tablets approved by the USFDA...
Brand Name : Pyrimethamine-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 20, 2020
Lead Product(s) : Pyrimethamine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Pyrimethamine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Tilde Sciences
Deal Size : Undisclosed
Deal Type : Acquisition
Tilde Sciences Acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals
Details : Through the acquisition, Tilda Sciences gain two medicines, Daraprim (pyrimethamine), approved for treatment of toxoplasmosis and Vecamyl (mecamylamine HCI), approved for management of hypertension, from Vyera Pharmaceuticals.
Brand Name : Daraprim
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 07, 2023
Lead Product(s) : Pyrimethamine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Tilde Sciences
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Pyrimethamine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Phoenixus
Deal Size : $0.6 million
Deal Type : Agreement
Details : Through the agreement, Phoenixus gains access to Daraprim, a prescription medication that contains pyrimethamine for the treatment of toxoplasmosis and Vecamyl (mecamylamine HCI), indicated for the management of moderately severe to severe essential hype...
Brand Name : Daraprim
Molecule Type : Small molecule
Upfront Cash : Undisclosed
August 01, 2023
Lead Product(s) : Pyrimethamine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Phoenixus
Deal Size : $0.6 million
Deal Type : Agreement
LOOKING FOR A SUPPLIER?